What Is a Pain Machine? From TENS to Brain Stimulation

“Pain machine” is a term people use to describe a surprisingly wide range of devices, from the portable TENS units sold at pharmacies to surgically implanted spinal cord stimulators, radiofrequency ablation probes, and even virtual reality headsets used during burn wound care. On the measurement side, there are machines designed not to relieve pain but to quantify it, applying calibrated pressure, cold, or heat to map how a person’s nervous system processes painful stimuli. The technology spans centuries of development, and the landscape in the 2020s looks nothing like it did even a decade ago.

TENS Units and How They Work

When most people say “pain machine,” they mean a transcutaneous electrical nerve stimulation (TENS) unit. These are small, battery-powered devices that send mild electrical pulses through adhesive electrode pads placed on the skin near the area that hurts. You can buy them over the counter, and physical therapists use them routinely in clinic. The basic idea traces back to gate control theory: the electrical signals from the device activate sensory nerve fibers that effectively compete with pain signals heading to the brain, partially closing the “gate” on pain perception.

The frequency of stimulation matters. Low-frequency TENS and high-frequency TENS appear to reduce pain through different pathways. Research in animal models has shown that the pain relief from low-frequency stimulation involves one class of the body’s natural opioid receptors, while high-frequency stimulation involves a different class.¹ This distinction has practical implications: if you use the same frequency every day, you can develop tolerance to the effect, much like the body adapts to a repeated dose of a painkiller. Alternating between frequencies may help maintain effectiveness over time.

One wrinkle with TENS research is the placebo effect. Studies comparing real TENS against sham TENS (where the device looks active but delivers no meaningful stimulation) have found that older adults in particular show a strong placebo response, with one study reporting roughly a 40% pain reduction even from sham stimulation in older individuals compared to about 15% in younger participants.² Meanwhile, designing a truly convincing placebo for device-based pain treatments is notoriously difficult. A systematic review of low back pain trials found that most placebo controls generated lower patient expectations than the real treatment, meaning patients could often sense which group they were in, potentially skewing results.³ This does not mean TENS is useless, but it does mean the true size of its benefit is harder to pin down than for a pill with a perfect sugar-pill control.

Implantable Spinal Cord Stimulators

For people whose chronic pain has not responded to simpler treatments, spinal cord stimulation (SCS) represents a more serious intervention. A surgeon implants small electrodes near the spinal cord, connected to a pulse generator usually placed under the skin of the abdomen or buttock. The device delivers electrical impulses that interfere with pain signals before they reach the brain. For decades, the working explanation was a direct application of gate control theory: stimulate the dorsal columns of the spinal cord and generate a tingling sensation (called paresthesia) that masks pain. Newer SCS therapies, however, deliver stimulation without producing any perceptible tingling at all, which has left researchers scrambling to explain why they still work. Proposed mechanisms include activation of pathways that project up to the brain and local modulation of nerve signaling at the spinal level.⁴

One of the most significant recent advances is closed-loop SCS. Traditional open-loop systems deliver a fixed electrical dose regardless of what the patient is doing. When you shift position, cough, or go from sitting to walking, the distance between the electrode and the spinal cord changes slightly, and the stimulation can feel too strong or too weak. Closed-loop systems solve this by measuring evoked compound action potentials (ECAPs), which are the spinal cord’s electrical responses to each pulse, and adjusting stimulation intensity in real time to keep activation within a therapeutic window.⁵ A randomized controlled trial comparing closed-loop to open-loop SCS found that the closed-loop approach reduced or eliminated unwanted sensations and provided a more consistent experience for patients.⁶

Non-Invasive Brain Stimulation

Rather than targeting the spinal cord, some pain machines aim directly at the brain. Two non-invasive techniques have been studied extensively: repetitive transcranial magnetic stimulation (rTMS), which uses a magnetic coil held against the scalp to induce electrical currents in specific brain regions, and transcranial direct current stimulation (tDCS), which passes a weak electrical current between electrodes placed on the head. Both are painless or only mildly uncomfortable during use.

A large Cochrane review pooling data from dozens of trials found that rTMS produced a small reduction in pain intensity in the short term, amounting to about a 7% decrease, which fell short of the minimum clinically important difference threshold of 15%. When the analysis was narrowed to high-frequency stimulation of the motor cortex specifically, the effect was somewhat larger at around 12%, still below the clinical threshold. tDCS fared slightly better on paper, with a pooled reduction of about 17%, which just barely met the clinically meaningful threshold, though the confidence interval stretched well below it.⁷ In practical terms, these are not home-run treatments for most chronic pain patients, but they may play a useful supporting role, and tDCS has been flagged as the most cost-effective of the brain stimulation approaches when looking at a single year of treatment.⁸

For patients with central post-stroke pain, a particularly stubborn condition, surgeons have gone further with deep brain stimulation (DBS) and motor cortex stimulation (MCS), both of which require surgery. A meta-analysis of 32 studies covering 330 patients found that both approaches produced meaningful improvement: DBS led to about a 49% reduction in pain scores, while MCS achieved about a 53% reduction, with roughly six in ten patients improving after either procedure.⁹ These are reserved for the most severe, treatment-resistant cases.

Radiofrequency Ablation

Radiofrequency ablation (RFA) takes a completely different approach. Instead of masking or modulating pain signals, it uses heat generated by radio waves to selectively destroy the small nerves responsible for transmitting pain from a particular area. A needle-like probe is guided to the target nerve under imaging, and the tip is heated to interrupt the nerve’s ability to send signals. The relief is not permanent because nerves regenerate, but it can last months.

For chronic low back pain, randomized controlled trials have consistently shown RFA outperforming sham procedures. One trial found a roughly 2.2-point drop in pain scores (on a 0–10 scale) six months after the procedure, compared to only a 0.6-point drop in the control group. Other trials reported even larger gaps at three months, with pain reductions of 3.7 points and 2.4 points in the treated groups versus 0.5 and 0.8 points in their respective controls.¹⁰ A newer variant called cooled RFA uses internally cooled probes that allow a larger treatment area and may be effective for joints that are difficult to reach with conventional probes.

Intrathecal Drug Delivery Pumps

Some pain machines skip the electricity entirely and deliver medication directly to the spinal fluid through an implanted pump. These intrathecal drug delivery systems (IDDS) consist of a small programmable pump placed under the skin, connected to a thin catheter that threads into the space surrounding the spinal cord. Because the drug goes straight to the central nervous system, far less medication is needed compared to oral dosing. The approach bypasses the digestive system and the blood-brain barrier, which means fewer systemic side effects.¹¹

In a patient satisfaction survey, about 64% of respondents reported good to excellent pain relief, and roughly 81% were highly satisfied with their pump. Three-quarters said their physical functioning improved, and nearly 90% reported a better quality of life. Perhaps most striking, about 79% of respondents had completely stopped or substantially reduced their use of oral opioids after getting the pump.¹² These devices are typically reserved for patients with severe, complex chronic pain who have exhausted other options, including people with cancer pain and those with failed back surgery syndrome.

Virtual Reality as a Pain Machine

Virtual reality headsets are a newer and perhaps unexpected entry in the pain machine category. Rather than electrically or chemically interfering with nerve signals, VR works by hijacking attention. Pain perception is heavily influenced by how much cognitive bandwidth you devote to it, and an immersive virtual environment can consume enough of that bandwidth to meaningfully blunt the experience. The strongest evidence so far comes from burn wound care, one of the most painful medical procedures patients regularly endure.

In one randomized trial, burn-injured children who used VR during dressing changes reported significantly less pain than children who received standard care alone, with average pain scores of about 2.6 versus 4.2 on a matched scale.¹³ Adult burn patients show similar patterns. An integrative review of VR in burn care found that active VR (where the patient interacts with a virtual environment) reduced pain intensity by about 79% in one trial’s treatment group, compared to 57% in the non-VR group, with the benefits persisting at six months.¹⁴ Active engagement appears to matter: in studies comparing interactive VR to passive virtual tours of the same scenery, patients who actively played games or controlled their environment reported lower worst pain scores and spent less time thinking about their pain.¹⁵

Machines That Measure Pain

Not every pain machine is designed to provide relief. A whole category exists to measure pain as precisely as possible, both in clinical diagnosis and in research settings. Quantitative sensory testing (QST) is the most comprehensive approach. It uses calibrated thermal and mechanical stimuli to assess how well a person perceives temperature, touch, pain, pressure, and vibration. A standardized QST protocol involves seven distinct tests measuring 13 parameters, typically conducted in a fixed order starting with thermal stimuli before moving to mechanical ones.¹⁶ QST is used primarily in patients with nerve pain to identify which sensory pathways are damaged or overactive.¹⁷

Pressure algometers are simpler, single-purpose devices that press a blunt tip against a specific body site with steadily increasing force until the person reports that the sensation has become painful. That force level is called the pressure pain threshold. These devices are commonly used to evaluate muscle pain conditions and to track whether a treatment is making tender points less sensitive over time. The digital versions are highly reliable, though research suggests they are better for monitoring treatment effects than for diagnosing a condition on their own.¹⁸ One ongoing challenge is that handheld algometers depend on the operator pressing at a consistent speed and angle, which introduces human error. Automated versions that control the rate of force application and let the participant stop the test independently are being developed to address this.¹⁹

The cold pressor test is one of the oldest and simplest pain-measurement protocols. You immerse your hand in cold water and researchers record how long until you say it hurts (pain threshold) and how long until you pull your hand out (pain tolerance). Among hundreds of published trials using this method, the most commonly reported water temperature is around 1°C, though guidelines for use in children recommend a warmer 10°C.²⁰ ²¹ Laser stimulators offer yet another approach, using brief pulses from a CO₂ laser to heat the outermost layer of skin and selectively activate the thin nerve fibers that carry pain and heat signals, while brain activity is recorded to create an objective readout of how the nervous system processes the stimulus.²²

AI-Powered Pain Detection

A newer frontier involves machines that try to detect and quantify pain without asking the patient anything at all. This matters enormously for people who cannot self-report: infants, patients with severe dementia, those under sedation, and people with cognitive disabilities. Artificial intelligence systems trained on facial expression data can identify the muscle movements associated with pain (furrowed brows, tightened eyelids, raised upper lips) and classify pain intensity from video footage.²³

One deep learning system trained to distinguish between no pain, mild pain, and significant pain requiring clinical intervention achieved accuracy and sensitivity scores of about 0.87 across all categories, using a specialized neural network that analyzes both the spatial pattern and the temporal sequence of facial movements.²⁴ Beyond the face, researchers are exploring multimodal approaches that combine facial analysis with physiological signals such as brain wave patterns from EEG, muscle electrical activity, and skin conductance changes.²⁵ None of these systems has replaced bedside clinical judgment yet, but they could eventually provide continuous, objective pain monitoring in intensive care units and during surgery recovery.

Pain Machines in the Animal Research Lab

Much of what we know about pain mechanisms comes from preclinical research, and that research relies on its own specialized hardware. The electronic von Frey aesthesiometer is one of the most widely used devices. It houses a rodent in an enclosure with a mesh floor, and a motorized unit underneath pushes a thin filament against the animal’s paw with steadily increasing force, automatically recording the exact force at which the paw is withdrawn.²⁶ The thermal probe test serves a similar function for heat sensitivity, applying controlled warming to a paw and measuring withdrawal latency, providing a complement to older methods like the hot plate test.²⁷ Newer automated versions aim to remove operator variability entirely, with high-precision devices validated for use in both rats and mice.²⁸

These lab instruments might seem far removed from the TENS unit in your medicine cabinet, but they are the machinery behind every analgesic drug and every new stimulation therapy that eventually reaches patients. When a pharmaceutical company claims a new drug reduces pain in clinical trials, the path to those trials almost certainly ran through a rodent paw withdrawal test first.

Security Risks of Implantable Pain Devices

As pain machines become more sophisticated and wirelessly connected, an unusual concern has emerged: cybersecurity. Modern spinal cord stimulators can be programmed via smartphone apps and communicate wirelessly with external controllers. That wireless capability, while convenient for patients and clinicians, theoretically opens a door to unauthorized access. A review of the technology found that based on the documented history of hacking in other implantable medical devices (cardiac pacemakers and insulin pumps have both been demonstrated as hackable), SCS systems may also be susceptible to manipulation.²⁹ No confirmed real-world attacks on spinal cord stimulators have been publicly reported, but as these devices increasingly rely on wireless control and mobile device compatibility, researchers have called on manufacturers and regulatory agencies to build in stronger safeguards. Broader reviews of technology-related medical incidents have noted that errors in spinal stimulators and harm from healthcare cyberattacks both represent emerging categories of patient risk in an increasingly connected medical landscape.³⁰

How Electric Fish Started It All

The idea of using a machine to control pain is far older than electronics. Ancient physicians applied live electric fish, particularly torpedo rays, to painful body parts to produce numbness. Once scientists in the mid-1700s figured out how to generate static electricity with frictional machines, the fish were retired. By the end of that century, Galvani had shown that animals produce electricity naturally, and Volta had invented the first battery, giving clinicians a reliable, controllable source of current for the first time.³¹ Every pain machine in use today, from the simplest TENS unit to a closed-loop spinal cord stimulator reading neural signals in real time, descends from that basic insight: electricity and the nervous system speak the same language, and you can use one to interrupt the other.